Infective endocarditis and antithrombotic therapy.
Cardiology
; 2024 Apr 04.
Article
em En
| MEDLINE
| ID: mdl-38574483
ABSTRACT
Incidence of infective endocarditis (IE) is progressively raising because of the increasing number of cardiovascular invasive procedures, support treatment and devices, awareness in the medical community and improved diagnostic modalities. IE pathophysiology is a unique model of immunothrombosis and the clinical course is often complicated by either thromboembolic or hemorrhagic events. Managing antithrombotic treatment is challenging and the level of supporting evidence scant. Aim of this review was to discuss and present the thromboembolic and bleeding complication associated with IE and review the available evidence on anti-thrombotic treatment in patients with IE with and without a previous indication to anti-thrombotic drugs.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Revista:
Cardiology
Ano de publicação:
2024
Tipo de documento:
Article